Logo image of PHOE

PHOENIX ASIA HOLDINGS LTD (PHOE) Stock Fundamental Analysis

NASDAQ:PHOE - KYG7075R1083 - Common Stock

7.41 USD
-0.15 (-1.98%)
Last: 9/8/2025, 12:21:15 PM
Fundamental Rating

5

PHOE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 52 industry peers in the Construction & Engineering industry. PHOE gets an excellent profitability rating and is at the same time showing great financial health properties. PHOE does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

PHOE had positive earnings in the past year.
PHOE had a positive operating cash flow in the past year.
PHOE Yearly Net Income VS EBIT VS OCF VS FCFPHOE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 200K 400K 600K 800K 1M

1.2 Ratios

PHOE's Return On Assets of 19.11% is amongst the best of the industry. PHOE outperforms 94.23% of its industry peers.
Looking at the Return On Equity, with a value of 33.00%, PHOE belongs to the top of the industry, outperforming 84.62% of the companies in the same industry.
PHOE's Return On Invested Capital of 34.07% is amongst the best of the industry. PHOE outperforms 94.23% of its industry peers.
PHOE had an Average Return On Invested Capital over the past 3 years of 44.64%. This is significantly above the industry average of 17.21%.
The 3 year average ROIC (44.64%) for PHOE is well above the current ROIC(34.07%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 19.11%
ROE 33%
ROIC 34.07%
ROA(3y)23.2%
ROA(5y)N/A
ROE(3y)49.56%
ROE(5y)N/A
ROIC(3y)44.64%
ROIC(5y)N/A
PHOE Yearly ROA, ROE, ROICPHOE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 20 40 60

1.3 Margins

PHOE has a better Profit Margin (13.92%) than 92.31% of its industry peers.
With an excellent Operating Margin value of 17.61%, PHOE belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
PHOE has a Gross Margin of 29.52%. This is amongst the best in the industry. PHOE outperforms 80.77% of its industry peers.
Industry RankSector Rank
OM 17.61%
PM (TTM) 13.92%
GM 29.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
PHOE Yearly Profit, Operating, Gross MarginsPHOE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 5 10 15 20 25

More info and screens

9

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PHOE is creating value.
Compared to 1 year ago, PHOE has about the same amount of shares outstanding.
Compared to 1 year ago, PHOE has an improved debt to assets ratio.
PHOE Yearly Shares OutstandingPHOE Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 5M 10M 15M 20M
PHOE Yearly Total Debt VS Total AssetsPHOE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 1M 2M 3M 4M 5M

2.2 Solvency

PHOE has an Altman-Z score of 46.87. This indicates that PHOE is financially healthy and has little risk of bankruptcy at the moment.
PHOE's Altman-Z score of 46.87 is amongst the best of the industry. PHOE outperforms 100.00% of its industry peers.
PHOE has a debt to FCF ratio of 0.02. This is a very positive value and a sign of high solvency as it would only need 0.02 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.02, PHOE belongs to the top of the industry, outperforming 94.23% of the companies in the same industry.
PHOE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of PHOE (0.00) is better than 92.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Altman-Z 46.87
ROIC/WACC3.41
WACC9.98%
PHOE Yearly LT Debt VS Equity VS FCFPHOE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 1M 2M 3M

2.3 Liquidity

PHOE has a Current Ratio of 2.24. This indicates that PHOE is financially healthy and has no problem in meeting its short term obligations.
PHOE's Current ratio of 2.24 is amongst the best of the industry. PHOE outperforms 94.23% of its industry peers.
PHOE has a Quick Ratio of 2.24. This indicates that PHOE is financially healthy and has no problem in meeting its short term obligations.
PHOE has a better Quick ratio (2.24) than 94.23% of its industry peers.
Industry RankSector Rank
Current Ratio 2.24
Quick Ratio 2.24
PHOE Yearly Current Assets VS Current LiabilitesPHOE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 1M 2M 3M 4M 5M

More info and screens

1

3. Growth

3.1 Past

PHOE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.86%.
The Revenue has grown by 28.06% in the past year. This is a very strong growth!
EPS 1Y (TTM)-2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
Revenue 1Y (TTM)28.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.06%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHOE Yearly Revenue VS EstimatesPHOE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2M 4M 6M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 148.20, PHOE can be considered very expensive at the moment.
Based on the Price/Earnings ratio, PHOE is valued a bit more expensive than the industry average as 67.31% of the companies are valued more cheaply.
PHOE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.02.
Industry RankSector Rank
PE 148.2
Fwd PE N/A
PHOE Price Earnings VS Forward Price EarningsPHOE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, PHOE is valued a bit more expensive than 71.15% of the companies in the same industry.
PHOE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. PHOE is more expensive than 61.54% of the companies in the same industry.
Industry RankSector Rank
P/FCF 140.49
EV/EBITDA 119.08
PHOE Per share dataPHOE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.1 0.2 0.3

4.3 Compensation for Growth

PHOE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

PHOE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PHOENIX ASIA HOLDINGS LTD

NASDAQ:PHOE (9/8/2025, 12:21:15 PM)

7.41

-0.15 (-1.98%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners74.54%
Ins Owner ChangeN/A
Market Cap160.06M
AnalystsN/A
Price TargetN/A
Short Float %2.97%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 148.2
Fwd PE N/A
P/S 21.72
P/FCF 140.49
P/OCF 135.59
P/B 51.46
P/tB 51.46
EV/EBITDA 119.08
EPS(TTM)0.05
EY0.67%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.05
FCFY0.71%
OCF(TTM)0.05
OCFY0.74%
SpS0.34
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 19.11%
ROE 33%
ROCE 41.45%
ROIC 34.07%
ROICexc 141.42%
ROICexgc 141.42%
OM 17.61%
PM (TTM) 13.92%
GM 29.52%
FCFM 15.46%
ROA(3y)23.2%
ROA(5y)N/A
ROE(3y)49.56%
ROE(5y)N/A
ROIC(3y)44.64%
ROIC(5y)N/A
ROICexc(3y)115.11%
ROICexc(5y)N/A
ROICexgc(3y)115.11%
ROICexgc(5y)N/A
ROCE(3y)54.33%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover1.37
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Debt/EBITDA 0.01
Cap/Depr 76.39%
Cap/Sales 0.56%
Interest Coverage 1622.12
Cash Conversion 87.34%
Profit Quality 111.01%
Current Ratio 2.24
Quick Ratio 2.24
Altman-Z 46.87
F-Score6
WACC9.98%
ROIC/WACC3.41
Cap/Depr(3y)42.62%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)28.06%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.06%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y5.27%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y110.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y118.47%
OCF growth 3YN/A
OCF growth 5YN/A